Chakraborty A K, Pawelek J, Ikeda Y, Miyoshi E, Kolesnikova N, Funasaka Y, Ichihashi M, Taniguchi N
Department of Dermatology, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06510, USA.
Cell Growth Differ. 2001 Dec;12(12):623-30.
It was shown previously that a majority of hybrids produced by in vitro fusion of normal macrophages with Cloudman S91 melanoma cells displayed enhanced metastatic potential in vivo, increased motility in vitro, increased ability to produce melanin, and responsiveness to melanocyte stimulating hormone compared with the parental Cloudman S91 melanoma cells. These hybrids also showed altered N-glycosylation consistent with a slower migration pattern of lysosome-associated membrane protein (LAMP-1) on electrophoretic gels. Because LAMP-1 is the major carrier of polylactosamine sugar structures, and synthesis of this complex sugar moiety indicates the extent of beta1,6 branch formation by beta1,6-N-acetyl-glucosaminyltransferase V (GnT-V), we analyzed the expression of GnT-V and beta1,6 branching in highly metastatic macrophage-fusion hybrids and compared with poorly metastatic ones. GnT-V was up-regulated in regard to both mRNA levels and enzymatic activity specifically in metastatic hybrids as well as parental macrophages compared with weakly metastatic hybrids and parental melanoma cells. Macrophages and metastatic hybrids also showed increased binding of the lectin L-phytohemagglutinin, which specifically binds to the beta1,6-branched sugar moiety. In addition, in metastatic hybrids there was increased cell surface expression of LAMP-1 and beta1 integrin, two prominent substrates for GnT-V also known to be associated with metastasis. Finally, exposure of metastatic hybrids in vitro to L-phytohemagglutinin or LAMP-1 completely eliminated melanocyte stimulating hormone/ isobutylmethyl xanthine-induced motility, suggesting a role for GnT-V in the motility of these cells. In summary, macrophage fusion with melanoma cells often increased metastatic potential, which was associated with enhanced expression of GnT-V and beta1,6-branching in glycoproteins. It is suggested that the known correlation with elevated GnT-V in both human and animal metastasis could, at least in some cases, reflect previous fusion of tumor cells with tumor-infiltrating macrophages, which, similar to malignant cells, show elevated expression of GnT-V and beta1,6-branched polylactosamines.
先前的研究表明,正常巨噬细胞与Cloudman S91黑色素瘤细胞通过体外融合产生的大多数杂交细胞在体内表现出增强的转移潜能,在体外具有更高的运动性,产生黑色素的能力增强,并且与亲代Cloudman S91黑色素瘤细胞相比,对促黑素细胞激素有反应。这些杂交细胞还表现出N-糖基化改变,这与溶酶体相关膜蛋白(LAMP-1)在电泳凝胶上较慢的迁移模式一致。由于LAMP-1是聚乳糖胺糖结构的主要载体,并且这种复合糖部分的合成表明β1,6-N-乙酰氨基葡萄糖转移酶V(GnT-V)形成β1,6分支的程度,我们分析了高转移性巨噬细胞融合杂交细胞中GnT-V的表达和β1,6分支情况,并与低转移性杂交细胞进行比较。与低转移性杂交细胞和亲代黑色素瘤细胞相比,GnT-V在转移性杂交细胞以及亲代巨噬细胞中的mRNA水平和酶活性方面均上调。巨噬细胞和转移性杂交细胞还表现出凝集素L-植物血凝素的结合增加,该凝集素特异性结合β1,6分支的糖部分。此外,在转移性杂交细胞中,LAMP-1和β1整合素的细胞表面表达增加,这两种GnT-V的主要底物也已知与转移有关。最后,在体外将转移性杂交细胞暴露于L-植物血凝素或LAMP-1可完全消除促黑素细胞激素/异丁基甲基黄嘌呤诱导的运动性,提示GnT-V在这些细胞的运动中起作用。总之,巨噬细胞与黑色素瘤细胞融合通常会增加转移潜能,这与糖蛋白中GnT-V表达增强和β1,6分支有关。有人提出,在人类和动物转移中已知的与GnT-V升高的相关性,至少在某些情况下,可能反映了肿瘤细胞与肿瘤浸润巨噬细胞先前的融合,后者与恶性细胞类似,显示出GnT-V和β1,6分支聚乳糖胺的表达升高。